Form 4: Exelixis EVP, Commercial, Patrick J. Haley, Executes Stock Option and Disposes of Shares for Tax Obligations
SEC Form 4 Filing
Patrick J. Haley, EVP, Commercial at Exelixis, exercised a stock option for 100,000 shares and disposed of 96,111 shares to cover the exercise price and tax obligations.
Summary
- On October 2, 2024, Patrick J. Haley, EVP, Commercial at Exelixis, exercised a stock option to purchase 100,000 shares of common stock at a price of $24.41 per share.
- Haley then disposed of 96,111 shares of common stock at $26.50 to cover the exercise price and tax withholding.
- Following these transactions, Haley directly owns 344,925 shares of Exelixis common stock, including 239,572 shares that will be issued upon vesting of restricted stock units.
- Haley also indirectly owns 10,648 shares through the Exelixis, Inc. 401(k) Plan and 23,539 shares through his spouse.
Sentiment
Score: 5
Explanation: The document reflects a neutral event (stock option exercise and tax obligation fulfillment) with no inherent positive or negative implications for the company's overall performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track executive compensation and ownership changes.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- The 'net exercise' of stock options, where shares are withheld to cover the exercise price and taxes, is a common practice.
- Companies like Amgen, Gilead Sciences, and Biogen also utilize stock options as part of their executive compensation plans.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it primarily concerns the executive's personal financial management.
- Shareholders may view insider transactions as a signal of management's confidence in the company, but this specific transaction is more related to compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 10/03/2018 | Original grant date of the option, representing the right to purchase a total of 100,000 shares of Common Stock |
| 10/03/2021 | The option became fully exercisable. |
| 10/01/2024 | Date of the Exelixis, Inc. 401(k) Plan statement. |
| 10/02/2024 | Date of the stock option exercise and share disposal. |
| 10/02/2024 | Expiration date of the option. |
| 10/03/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.